Sonim Technologies completes 1-for-10 reverse stock split effective July 17, 2024

DNA X, Inc.

Reverse stock split ratio 1-for-10 approved by board after stockholder authorization at June 20, 2024 annual meeting.
Certificate of amendment filed with Delaware; effective 5:00 p.m. ET on July 17, 2024.
Every ten shares combined into one; no fractional shares, one full share issued for any fractional.
Common stock to trade split-adjusted under symbol SONM from July 18, 2024; new CUSIP 83548F309.
Stockholders authorized split at ratio range 1:2 to 1:15; board set final ratio at 1:10.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.